RECRUITING

Implementing an Effective Diabetes Intervention Among Low-Income Immigrants

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this IDEAL project is to examine the effectiveness and implementation process of the video-based Diabetes Self-Management Education and Support (DSMES) + community health worker (CHW) (hereafter: "IDEAL") intervention compared with a wait-list control group (hereafter: "CONTROL") to improve glycemic control among Chinese immigrants with Type 2 diabetes (T2D) in New York City (NYC). Participants will be randomized with equal allocation to one of the 2 groups. The IDEAL group will receive 1 DSMES brief video/week for 24 weeks delivered via text message. The CHW will assess participants' SDOH barriers to T2D care and link them to available resources in the community. The CONTROL group will continue to receive their usual care and at the end of the study, they will receive DSMES videos.

Official Title

IDEAL: Implementing an Effective Diabetes intervEntion Among Low-income Immigrants

Quick Facts

Study Start:2024-12-29
Study Completion:2028-06-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06319703

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 70 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. self-identify as a Chinese immigrant;
  2. 2. be between 18-70 years old,
  3. 3. have a diagnosis of T2D in the medical record;
  4. 4. have had an appointment with a physician for routine T2D care within the past 12 months;
  5. 5. have a most recent HbA1c \> or = 8%;
  6. 6. be willing to receive brief videos regarding T2D management, and
  7. 7. possess a smartphone or, if they do not have one, be willing and able to use a study smartphone.
  1. 1. unable or unwilling to provide informed consent;
  2. 2. unable to participate meaningfully in the intervention (e.g., uncorrected sight and hearing impairment);
  3. 3. unwilling to accept randomization assignment;
  4. 4. is pregnant, plans to become pregnant in the next 6 months, or becomes pregnant during the study, or
  5. 5. is breastfeeding (e.g., they may have potential dietary restrictions).

Contacts and Locations

Study Contact

Lu Hu, PhD
CONTACT
646-501-3438
Lu.hu@nyulangone.org

Principal Investigator

Lu Hu, PhD
PRINCIPAL_INVESTIGATOR
NYU School of Medicine

Study Locations (Sites)

NYU Langone Health
New York, New York, 10016
United States

Collaborators and Investigators

Sponsor: NYU Langone Health

  • Lu Hu, PhD, PRINCIPAL_INVESTIGATOR, NYU School of Medicine

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-12-29
Study Completion Date2028-06-30

Study Record Updates

Study Start Date2024-12-29
Study Completion Date2028-06-30

Terms related to this study

Keywords Provided by Researchers

  • Mobile Health
  • mHealth

Additional Relevant MeSH Terms

  • Type 2 Diabetes